{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T18:14:18Z","timestamp":1775412858139,"version":"3.50.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":1279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.micinf.2020.05.004","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:12:52Z","timestamp":1589155972000},"page":"245-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development"],"prefix":"10.1016","volume":"22","author":[{"given":"Cuiqing","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiachao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanying","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2020.05.004_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A\u00a0novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2020.05.004_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jmv.25674","article-title":"Recent advances in the detection of respiratory virus infection in humans","volume":"92","author":"Zhang","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s12250-020-00206-5","article-title":"The first disease X is caused by a highly transmissible acute respiratory syndrome coronavirus","author":"Jiang","year":"2020","journal-title":"Virol Sin"},{"key":"10.1016\/j.micinf.2020.05.004_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.micinf.2020.01.003","article-title":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China","volume":"22","author":"Yu","year":"2020","journal-title":"Microb Infect"},{"key":"10.1016\/j.micinf.2020.05.004_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndromerelated coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.micinf.2020.05.004_bib7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A\u00a0familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.05.004_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.05.004_bib9","author":"Messonnier"},{"key":"10.1016\/j.micinf.2020.05.004_bib10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1056\/NEJMc2001272","article-title":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","volume":"382","author":"Phan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2020.05.004_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41423-020-0372-4","article-title":"A\u00a0novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome","volume":"17","author":"Jiang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.micinf.2020.05.004_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.05.004_bib13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2020.05.004_bib14","article-title":"Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China","author":"Liu","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.micinf.2020.05.004_bib15","article-title":"Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions","author":"Read","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.micinf.2020.05.004_bib16","article-title":"Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China","author":"Shen","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.micinf.2020.05.004_bib17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/01.ede.0000181633.80269.4c","article-title":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future","volume":"16","author":"Bauch","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.micinf.2020.05.004_bib18","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.05.004_bib19","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(03)13410-1","article-title":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong","volume":"361","author":"Donnelly","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.05.004_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.05.004_bib21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2020.05.004_bib22","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/JVI.06540-11","volume":"86","author":"Woo","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.micinf.2020.05.004_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tim.2016.09.001","article-title":"Molecular evolution of human coronavirus genomes","volume":"25","author":"Forni","year":"2017","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.micinf.2020.05.004_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.micinf.2020.05.004_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmv.25688","article-title":"The 2019-new coronavirus epidemic: evidence for virus evolution","volume":"92","author":"Benvenuto","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A\u00a0pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.05.004_bib28","article-title":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin","author":"Zhou","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.micinf.2020.05.004_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.05.004_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS","volume":"94","author":"Wan","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2020.05.004_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2020.05.004_bib33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/eid1107.050219","article-title":"SARS vaccine development","volume":"11","author":"Jiang","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.micinf.2020.05.004_bib34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.bbrc.2004.01.166","article-title":"Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments","volume":"315","author":"Zeng","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.micinf.2020.05.004_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV - a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.micinf.2020.05.004_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1747-0285.2008.00746.x","article-title":"Peptide nanoparticles as novel immunogens: design and analysis of a prototypic Severe Acute Respiratory Syndrome Vaccine","volume":"73","author":"Pimentel","year":"2009","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.micinf.2020.05.004_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1358\/dot.2008.44.1.1131830","article-title":"Development of subunit vaccines against severe acute respiratory syndrome","volume":"44","author":"Du","year":"2008","journal-title":"Drugs Today (Barc)."},{"key":"10.1016\/j.micinf.2020.05.004_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Thanh Le","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.micinf.2020.05.004_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.imlet.2004.06.014","article-title":"Immunogenicity of SARS inactivated vaccine in BALB\/c mice","volume":"95","author":"Xiong","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.micinf.2020.05.004_bib40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/intimm\/dxh143","article-title":"A\u00a0subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice","volume":"16","author":"Takasuka","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.micinf.2020.05.004_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/104454904323145272","article-title":"Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB\/c mice","volume":"23","author":"Tang","year":"2004","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.micinf.2020.05.004_bib42","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1016\/j.vaccine.2006.04.054","article-title":"Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine","volume":"24","author":"He","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.05.004_bib43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbrc.2004.10.052","article-title":"Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry","volume":"325","author":"He","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.micinf.2020.05.004_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/2965cfae-b77d-4014-8b7b-236e01a35492","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2020.05.004_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physiolgenomics.00102.2004","article-title":"Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV","volume":"18","author":"Wang","year":"2004","journal-title":"Physiol Genom"},{"key":"10.1016\/j.micinf.2020.05.004_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12250-018-0009-2","article-title":"Evaluation of antibody-dependent enhancement of SARS-CoV infection in rhesus macaques immunized with an inactivated SARS-CoV vaccine","volume":"33","author":"Luo","year":"2018","journal-title":"Virol Sin"},{"key":"10.1016\/j.micinf.2020.05.004_bib47","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nbt.1635","article-title":"Rationalizing the development of live attenuated virus vaccines","volume":"28","author":"Lauring","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.micinf.2020.05.004_bib48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm1726","article-title":"Engineering attenuated virus vaccines by controlling replication fidelity","volume":"14","author":"Vignuzzi","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2020.05.004_bib49","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.micinf.2020.05.004_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.virusres.2005.02.009","article-title":"Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats","volume":"112","author":"Liu","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.micinf.2020.05.004_bib51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virol.2006.03.049","article-title":"Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: implication for developing SARS vaccines","volume":"353","author":"Du","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2020.05.004_bib52","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(04)16501-X","article-title":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS","volume":"363","author":"Bukreyev","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.05.004_bib53","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"Du","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.05.004_bib54","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib55","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/nm.2972","article-title":"A\u00a0live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease","volume":"18","author":"Graham","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2020.05.004_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-018-0175-7","article-title":"Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform","volume":"1","author":"Graham","year":"2018","journal-title":"Commun Biol"},{"key":"10.1016\/j.micinf.2020.05.004_bib57","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/135965350701200702","article-title":"Safety and immunogenicity from a Phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine","volume":"12","author":"Lin","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.micinf.2020.05.004_bib58","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1016\/j.vaccine.2008.09.026","article-title":"A\u00a0SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial","volume":"26","author":"Martin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.05.004_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib60","doi-asserted-by":"crossref","first-page":"eaav4580","DOI":"10.1126\/sciadv.aav4580","article-title":"A\u00a0pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.micinf.2020.05.004_bib61","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"Bat-to-human: spike features determining \u2018host jump\u2019of coronaviruses SARS-CoV, MERS-CoV, and beyond","volume":"23","author":"Lu","year":"2015","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.micinf.2020.05.004_bib62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2016.07.015","article-title":"MERS-CoV spike protein: targets for vaccines and therapeutics","volume":"133","author":"Wang","year":"2016","journal-title":"Antivir Res"},{"key":"10.1016\/j.micinf.2020.05.004_bib63","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","article-title":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine","volume":"324","author":"He","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.micinf.2020.05.004_bib64","first-page":"1","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","author":"Xia","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.micinf.2020.05.004_bib65","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1099\/0022-1317-81-12-2867","article-title":"Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity","volume":"81","author":"Taguchi","year":"2000","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib66","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.str.2006.03.007","article-title":"Structures and polymorphic interactions of two heptad-repeat regions of the SARS virus S2 protein","volume":"14","author":"Deng","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.micinf.2020.05.004_bib67","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/22221751.2020.1723441","article-title":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies","volume":"9","author":"Jiang","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.micinf.2020.05.004_bib68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.compbiolchem.2005.04.008","article-title":"A\u00a0molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2","volume":"29","author":"Zhang","year":"2005","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.micinf.2020.05.004_bib69","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","article-title":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2","volume":"24","author":"Li","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.micinf.2020.05.004_bib70","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1073\/pnas.0409608102","article-title":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human","volume":"102","author":"Song","year":"2005","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.micinf.2020.05.004_bib71","doi-asserted-by":"crossref","first-page":"29588","DOI":"10.1074\/jbc.M500662200","article-title":"Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy","volume":"280","author":"Qu","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2020.05.004_bib72","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1128\/JVI.00442-08","article-title":"Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections","volume":"82","author":"Li","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib73","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2013.08.014","article-title":"Receptor recognition and cross-species infections of SARS coronavirus","volume":"100","author":"Li","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.micinf.2020.05.004_bib74","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1074\/jbc.M111.325803","article-title":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus","volume":"287","author":"Wu","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2020.05.004_bib75","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A\u00a0193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2020.05.004_bib76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2006.03.139","article-title":"A\u00a0single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity","volume":"344","author":"He","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.micinf.2020.05.004_bib77","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.micinf.2020.05.004_bib78","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.vaccine.2006.08.011","article-title":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate Fc\u03b3RII-dependent entry into B cells in\u00a0vitro","volume":"25","author":"Kam","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.05.004_bib79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/vim.2009.0090","article-title":"A\u00a0219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity","volume":"23","author":"Du","year":"2010","journal-title":"Viral Immunol"},{"key":"10.1016\/j.micinf.2020.05.004_bib80","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2009.07.018","article-title":"Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity","volume":"393","author":"Du","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2020.05.004_bib81","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1128\/JVI.00083-06","article-title":"Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design","volume":"80","author":"He","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib82","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1128\/JVI.00671-11","article-title":"Anti-severe Acute Respiratory Syndrome Coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-Independent Fc\u03b3R pathway","volume":"85","author":"Jaume","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib83","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","article-title":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins","volume":"451","author":"Wang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 2","key":"10.1016\/j.micinf.2020.05.004_bib84","first-page":"31","article-title":"SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement","volume":"18","author":"Jaume","year":"2012","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.micinf.2020.05.004_bib85","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.micinf.2020.05.004_bib86","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-1-4615-1325-4_51","article-title":"The role of CD4 and CD8 T cells in MHV-JHM-induced demyelination","volume":"494","author":"Wu","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.micinf.2020.05.004_bib87","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/acsinfecdis.6b00006","article-title":"Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates","volume":"2","author":"Wang","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.micinf.2020.05.004_bib88","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/JVI.79.5.2678-2688.2005","article-title":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region","volume":"79","author":"Chen","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib89","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2005.01.034","article-title":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines","volume":"334","author":"He","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2020.05.004_bib90","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2005.01.050","article-title":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein","volume":"335","author":"Zhi","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2020.05.004_bib91","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbrc.2009.05.003","article-title":"Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells","volume":"384","author":"Du","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.micinf.2020.05.004_bib92","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","article-title":"Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies","volume":"174","author":"He","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.05.004_bib93","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14728222.2017.1271415","article-title":"MERS-CoV spike protein: a key target for antivirals","volume":"21","author":"Du","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.micinf.2020.05.004_bib94","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/v11010060","article-title":"Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain","volume":"11","author":"Zhou","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2020.05.004_bib95","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.vaccine.2006.10.031","article-title":"Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model","volume":"25","author":"Du","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.05.004_bib96","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.vaccine.2008.01.025","article-title":"Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection","volume":"26","author":"Du","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.05.004_bib97","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1016\/j.vaccine.2014.08.086","article-title":"Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments\u2014the importance of immunofocusing in subunit vaccine design","volume":"32","author":"Ma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.05.004_bib98","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.4049\/jimmunol.176.10.6085","article-title":"Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein","volume":"176","author":"He","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.05.004_bib99","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.micinf.2020.05.004_bib100","doi-asserted-by":"crossref","first-page":"37131","DOI":"10.1038\/srep37131","article-title":"SARS-CoV fusion peptides induce membrane surface ordering and curvature","volume":"6","author":"Basso","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.micinf.2020.05.004_bib101","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-0-387-73657-0_69","article-title":"Expression and characterization of recombinant S2 subunit of SARS-coronavirus S fusion protein","volume":"611","author":"Yan","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.micinf.2020.05.004_bib102","first-page":"1","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2020.05.004_bib103","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1038\/emi.2017.50","article-title":"A\u00a0novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein","volume":"6","author":"Chen","year":"2017","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.micinf.2020.05.004_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050366","article-title":"Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing","volume":"7","author":"Elshabrawy","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2020.05.004_bib105","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/dna.2005.24.510","article-title":"Elicitation of immunity in mice after immunization with the S2 subunit of the severe acute respiratory syndrome coronavirus","volume":"24","author":"Guo","year":"2005","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.micinf.2020.05.004_bib106","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1016\/j.febslet.2006.08.085","article-title":"Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit","volume":"580","author":"Zeng","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.micinf.2020.05.004_bib107","doi-asserted-by":"crossref","first-page":"15748","DOI":"10.1073\/pnas.0403812101","article-title":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus","volume":"101","author":"Jeffers","year":"2004","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.micinf.2020.05.004_bib108","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1128\/JVI.78.11.5642-5650.2004","article-title":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN","volume":"78","author":"Yang","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib109","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1128\/JVI.00315-07","article-title":"Specific asparagine-linked glycosylation sites are critical for DC-SIGN-and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry","volume":"81","author":"Han","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.05.004_bib110","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14760584.2014.912134","article-title":"Current advancements and potential strategies in the development of MERS-CoV vaccines","volume":"13","author":"Zhang","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.micinf.2020.05.004_bib111","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/cmi.2015.03","article-title":"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus","volume":"13","author":"Zhang","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.micinf.2020.05.004_bib112","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/423467a","article-title":"Virus detectives seek source of SARS in China\u2019s wild animals","volume":"423","author":"Cyranoski","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.05.004_bib113","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Guan","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.micinf.2020.05.004_bib114","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.micinf.2020.05.004_bib115","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1073\/pnas.0506735102","article-title":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats","volume":"102","author":"Lau","year":"2005","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.micinf.2020.05.004_bib116","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.med.60.041807.123500","article-title":"Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease","volume":"61","author":"Whitsett","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.micinf.2020.05.004_bib117","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature12306","article-title":"cGAS produces a 2\u2019-5\u2019-linked cyclic dinucleotide second messenger that activates STING","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.05.004_bib118","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.micinf.2020.05.004_bib119","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1244040","article-title":"Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects","volume":"341","author":"Li","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.micinf.2020.05.004_bib120","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau0810","article-title":"Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity","volume":"367","author":"Wang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.micinf.2020.05.004_bib121","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"Whitehead","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.micinf.2020.05.004_bib122","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/d41586-020-00751-9","article-title":"Don\u2019t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees","volume":"579","author":"Jiang","year":"2020","journal-title":"Nature"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457920300824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457920300824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:38:20Z","timestamp":1761143900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457920300824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":121,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1286457920300824"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2020.05.004","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2020.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}